Showing results (91-100 of 131) with videos related to
Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06C B Scott, C Scarantino, R Urtasun, et al.Cancer|November 25, 1992
Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease)S A Rosenthal, W J Curran, S H Herbert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06J S Lee, C Scott, R Komaki, et al.Cell Death and Differentiation|April 29, 2014
Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosisB Wang, M Xie, R Li, et al.Cancer|November 15, 1994
White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02)B W Corn, D M Yousem, C B Scott, et al.International Journal of Radiation Oncology, Biology, Physics|January 11, 1991
Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG reportT F Pajak, G E Laramore, V A Marcial, et al.British Journal of Cancer|April 14, 2011
Early toxicity predicts long-term survival in high-grade gliomaY R Lawrence, M Wang, A P Dicker, et al.International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancerC J Langer, W J Curran, S M Keller, et al.Cancer|May 1, 1995
Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15R W Byhardt, C B Scott, D S Ettinger, et al.International Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Immediate side effects of stereotactic radiotherapy and radiosurgeryM Werner-Wasik, S Rudoler, P E Preston, et al.Pageof 14